Flexible Savings Arrangements for a Healthy Robust America Act
Summary
HR2667 would allow FSA/HRA funds to roll tax-free into HSAs upon HDHP enrollment, expanding the addressable market for HSA administrators and HDHP issuers. The bill is at early stage (referred to Ways and Means, no appropriations). Recent 30-day gains for UNH (+36.1%), HUM (+40.2%) and CVS (+16.4%) are driven by broader sector momentum, not this bill alone. Near-term market impact is limited due to early legislative stage.
See which stocks are affected
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
Key Takeaways
- 1.HR2667 would allow FSA/HRA funds to roll tax-free into HSAs upon HDHP enrollment, expanding HSA asset inflows by removing the use-it-or-lose-it barrier.
- 2.The bill is in early stage (Ways and Means referral, 2 cosponsors) with low near-term passage probability; no companion Senate bill exists.
- 3.Recent 30-day rallies in UNH (+36%), HUM (+40%), and CVS (+16%) are driven by broader sector momentum, not HR2667.
- 4.Structural beneficiaries are HSA administrators (Optum/UNH) and HDHP issuers (UNH, CVS, HUM), but impact is contingent on passage.
- 5.Revenue impact is modest — if passed, estimated $15M-$60M annually across the sector from expanded HSA contributions and HDHP enrollment.
Market Implications
The bill alone has not moved stocks. UNH ($368.22) has rallied 36% in 30 days, HUM ($243.09) 40%, and CVS ($83.57) 16% — all trading at or near their 52-week highs. These moves correlate with broader healthcare sector momentum (Medicare Advantage rate finalization, strong earnings cycles) rather than tax policy expectations. If HR2667 gains legislative traction — e.g., committee markup, addition of bipartisan cosponsors, or folding into year-end tax extenders — HSA administrators and HDHP-centric insurers would see incremental upside. Near-term, the major managed care names are already pricing in substantial sector optimism; HR2667 is not a catalyst for current levels.
Full Analysis
On April 7, 2025, Rep. Bean (R-FL) introduced HR2667, the Flexible Savings Arrangements for a Healthy Robust America Act, with 2 cosponsors (Reps. Panetta (D-CA) and Crenshaw (R-TX)). The bill was referred to the House Committee on Ways and Means, where it remains. This is an early-stage authorization bill with no appropriations — it authorizes a change in tax treatment, not government spending.
The bill amends Internal Revenue Code Sections 106(e)(2) and 223(b)(4) to allow a one-time qualified HSA distribution from a health FSA or HRA directly into an HSA, capped at the Sec. 125(i)(1) limit (2026: $1,700 for self-only, $3,400 for family coverage). This eliminates the current 'use-it-or-lose-it' barrier that discourages FSA holders from switching to HDHPs, effectively converting trapped FSA balances into HSA funding.
The structural winners are HSA administrators and HDHP issuers. The largest HSA administrator is Optum Bank (UnitedHealth Group, $UNH), which held ~$17 billion in HSA assets as of 2025. HSA Bank (Webster Financial, $WBS) and Fidelity ($FNF) are also major players. Among HDHP issuers, UnitedHealthcare ($UNH), Aetna/CVS ($CVS), Humana, and Blue Cross Blue Shield affiliates stand to benefit from increased HDHP adoption.
Recent market data shows strong 30-day returns for UNH (+36.1% to $368.22), HUM (+40.2% to $243.09), and CVS (+16.4% to $83.57). These movements are significantly larger than the 30th-percentile sector gains, indicating broader momentum in healthcare stocks — likely tied to Medicare Advantage rate announcements, earnings reports, and general sector rotation — rather than price action driven by this early-stage bill. No stock-specific news links HR2667 to the observed price moves.
Legislative timeline: The bill must clear Ways and Means (chaired by Rep. Jason Smith, R-MO), pass the House, then clear the Senate Finance Committee and full Senate. With only 2 cosponsors and a 2025 introduction, this bill is in early, low-probability territory. No companion bill has been introduced in the Senate. The 119th Congress runs through January 2027, providing a two-year window, but the bill faces significant competition for legislative attention. Actual enactment is a low-probability event absent a larger healthcare tax package.
Intelligence Surface
Cross-referenced against federal contracts, SEC insider filings & congressional trade disclosures
Multiple independent sources confirm this signal’s market thesis
What the bill does
Tax code amendment allowing pre-tax FSA/HRA funds to roll directly into an HSA upon HDHP enrollment
Who must act
Employers offering both an FSA/HRA and an HDHP with an HSA option
What happens
Increased pool of pre-tax dollars eligible for HSA contributions; removes the 'use-it-or-lose-it' barrier for FSA holders transitioning to HDHPs, expanding the annual addressable HSA contribution flow by an estimated $1,000-$2,000 per converting employee
Stock impact
UnitedHealth's Optum Bank HSA business and its UnitedHealthcare HDHP offerings benefit from higher HSA asset inflows (management fees) and higher HDHP premium volume. Optum's HSA administration revenue grows proportionally to new HSA contributions. UNH is the largest HSA administrator by deposits.
What the bill does
Tax code amendment allowing pre-tax FSA/HRA funds to roll directly into an HSA upon HDHP enrollment
Who must act
Employers and consumers purchasing HDHPs from Aetna (CVS's health insurance subsidiary)
What happens
Higher HDHP enrollment through Aetna increases medical premium revenue and pharmacy benefit claim volume through CVS Caremark (PBM), both of which benefit when a new member selects an Aetna HDHP paired with an HSA
Stock impact
CVS's Aetna segment sells HDHPs under its commercial product line. Any policy that expands HDHP adoption benefits Aetna's commercial enrollment. Additionally, CVS Caremark processes prescriptions for these members. The bill's effect is structural but modest relative to CVS's $350B+ revenue base.
Connected Signals
Matched on shared policy language across AI analyses, with ticker & timing weight
Consolidated Appropriations Act, 2026
Protecting Health Care and Lowering Costs Act of 2025
To amend title XVIII of the Social Security Act to ensure stability for provider payments under the Medicare program.
TRIWEST HEALTHCARE ALLIANCE CORP: $820M Department of Veterans Affairs Contract
Association Health Plans Act
Protecting Health Care and Lowering Costs Act
Living Donor Protection Act of 2025
I CAN Act
Related Presidential Actions
Executive orders & memoranda affecting the same sectors or companies
National Homeownership Month, 2026
This proclamation formalizes National Homeownership Month and details several ongoing or proposed policy actions: Fannie Mae and Freddie Mac are directed to purchase $200 billion in mortgage-backed securities to lower borrowing costs; an executive order bans large institutional investors from buying single-family homes; and the Administration calls on Congress to pass the 21st Century ROAD to Housing Act to make these reforms permanent. The action also reaffirms efforts to restrict taxpayer-backed loans to only law-abiding citizens, targeting fraud and illegal immigration as a means to improve housing affordability.
Implementing Schedule Policy/Career in the Excepted Service
This executive order expands the Schedule Policy/Career excepted service category, transferring certain federal positions from competitive service to at-will employment to facilitate removal for poor performance or misconduct. It directs agency heads to petition for reclassification of policy-influencing roles, mandates performance bonus pools for these employees, and amends civil service rules to exempt them from standard adverse action procedures.
Realigning United States Core Childhood Vaccine Recommendations with Best Practices from Peer, Developed Countries
This executive order directs the CDC and ACIP to review and potentially update the U.S. childhood vaccine schedule to align with recommendations from peer developed countries, which recommend fewer vaccines. It maintains insurance coverage for all currently available vaccines without cost sharing and emphasizes protecting religious liberty and parental authority.